The prognostic impact of lead times in colorectal cancer patients undergoing cytoreductive surgery and HIPEC
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The prognostic impact of lead times in colorectal cancer patients undergoing cytoreductive surgery and HIPEC ; volume:20 ; number:1 ; day:19 ; month:9 ; year:2022 ; pages:1-8 ; date:12.2022
World journal of surgical oncology ; 20, Heft 1 (19.9.2022), 1-8, 12.2022
- Urheber
-
Jansson, Ylva
Graf, Wilhelm
Ghanipour, Lana
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-022-02765-1
- URN
-
urn:nbn:de:101:1-2022120621052857167287
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jansson, Ylva
- Graf, Wilhelm
- Ghanipour, Lana
- SpringerLink (Online service)
Ähnliche Objekte (12)
Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review
Predictors of Recurrence of Peritoneal Carcinomatosis among Patients with Colorectal Cancer Following Cytoreductive Surgery alone versus Cytoreductive Surgery Plus HIPEC
ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC
Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
Cytoreductive surgery and HIPEC in colorectal cancer—did we get hold of the wrong end of the stick?
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis
Comparative Analysis of Postoperative Complications after Cytoreductive Surgery and HIPEC in Gastric Cancer
Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases
Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review
Predictors of Recurrence of Peritoneal Carcinomatosis among Patients with Colorectal Cancer Following Cytoreductive Surgery alone versus Cytoreductive Surgery Plus HIPEC
ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC
Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
Cytoreductive surgery and HIPEC in colorectal cancer—did we get hold of the wrong end of the stick?
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis
Comparative Analysis of Postoperative Complications after Cytoreductive Surgery and HIPEC in Gastric Cancer
Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases
Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review
Predictors of Recurrence of Peritoneal Carcinomatosis among Patients with Colorectal Cancer Following Cytoreductive Surgery alone versus Cytoreductive Surgery Plus HIPEC
ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC
Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?
Cytoreductive surgery and HIPEC in colorectal cancer—did we get hold of the wrong end of the stick?
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis
Comparative Analysis of Postoperative Complications after Cytoreductive Surgery and HIPEC in Gastric Cancer